Feihu Xie

514 total citations
12 papers, 334 citations indexed

About

Feihu Xie is a scholar working on Oncology, Hepatology and Biomedical Engineering. According to data from OpenAlex, Feihu Xie has authored 12 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Hepatology and 4 papers in Biomedical Engineering. Recurrent topics in Feihu Xie's work include Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and 3D Printing in Biomedical Research (3 papers). Feihu Xie is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and 3D Printing in Biomedical Research (3 papers). Feihu Xie collaborates with scholars based in China and United States. Feihu Xie's co-authors include Huayu Yang, Yilei Mao, Wei Sun, Yuan Pang, Lejia Sun, Bao Jin, Gang Xu, Xinting Sang, Hongbing Zhang and Haitao Zhao and has published in prestigious journals such as Biomaterials, RSC Advances and Frontiers in Oncology.

In The Last Decade

Feihu Xie

11 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feihu Xie China 6 229 145 71 63 55 12 334
Preety Rawal India 9 156 0.7× 88 0.6× 84 1.2× 26 0.4× 79 1.4× 16 355
Weijie Zhao China 10 355 1.6× 43 0.3× 64 0.9× 29 0.5× 71 1.3× 18 447
Hyun Ju Hwang South Korea 9 164 0.7× 180 1.2× 35 0.5× 10 0.2× 74 1.3× 22 354
Neda Dadgar United States 13 125 0.5× 97 0.7× 104 1.5× 7 0.1× 97 1.8× 37 385
Oskar Rosmark Sweden 10 126 0.6× 60 0.4× 150 2.1× 9 0.1× 44 0.8× 13 352
Gilles van Tienderen Netherlands 8 161 0.7× 192 1.3× 106 1.5× 5 0.1× 90 1.6× 12 421
Shicheng Ye Netherlands 6 198 0.9× 59 0.4× 113 1.6× 11 0.2× 116 2.1× 8 367
Louis Jun Ye Ong Australia 9 289 1.3× 40 0.3× 18 0.3× 54 0.9× 45 0.8× 17 353
Nassim Rousset Switzerland 10 303 1.3× 87 0.6× 54 0.8× 21 0.3× 57 1.0× 12 395
Leona Smith United States 4 152 0.7× 70 0.5× 173 2.4× 21 0.3× 64 1.2× 7 363

Countries citing papers authored by Feihu Xie

Since Specialization
Citations

This map shows the geographic impact of Feihu Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feihu Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feihu Xie more than expected).

Fields of papers citing papers by Feihu Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feihu Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feihu Xie. The network helps show where Feihu Xie may publish in the future.

Co-authorship network of co-authors of Feihu Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Feihu Xie. A scholar is included among the top collaborators of Feihu Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feihu Xie. Feihu Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chen, Liang, et al.. (2025). PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching Study. ImmunoTargets and Therapy. Volume 14. 51–63. 1 indexed citations
2.
Hu, Zhigang, et al.. (2024). Research progress of flexible pressure sensor based on MXene materials. RSC Advances. 14(14). 9547–9558. 10 indexed citations
3.
Chen, Liang, Qiang Tao, Lingmin Jiang, et al.. (2023). From Conversion to Resection for Unresectable Hepatocellular Carcinoma: A Review of the Latest Strategies. Journal of Clinical Medicine. 12(24). 7665–7665. 3 indexed citations
4.
Yang, Jing, Yingbin Zheng, Liang Chen, et al.. (2022). Immunotherapy combination with regorafenib for refractory hepatocellular carcinoma: A real-world study. International Immunopharmacology. 113(Pt B). 109401–109401. 5 indexed citations
5.
Yan, Yangyang, Shaowen Cheng, Ping Zhou, et al.. (2022). Concave octopus-like PtCu nanoframe mediated photo-electro Fenton catalysis for fast organic dyestuff elimination. Nanoscale Advances. 4(13). 2782–2786. 4 indexed citations
6.
Sun, Lejia, Huayu Yang, Yanan Wang, et al.. (2020). Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research. Frontiers in Oncology. 10. 878–878. 77 indexed citations
7.
Mao, Shuangshuang, Jianyu He, Yu Zhao, et al.. (2020). Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing. Biofabrication. 12(4). 45014–45014. 80 indexed citations
8.
Sun, Lejia, Weiyu Xu, Huanhuan Yin, et al.. (2020). γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma. World Journal of Gastrointestinal Oncology. 12(9). 1014–1030. 5 indexed citations
9.
Xie, Feihu, Lejia Sun, Yuan Pang, et al.. (2020). Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine. Biomaterials. 265. 120416–120416. 99 indexed citations
10.
Sun, Lejia, Qing Wang, Meixi Liu, et al.. (2020). Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver disease. Endocrine. 69(2). 294–302. 19 indexed citations
11.
Xu, Gang, Lejia Sun, Yunzhu Li, et al.. (2019). The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis. Frontiers in Oncology. 9. 897–897. 31 indexed citations
12.
Zheng, Yongchang, Xin Wang, Feihu Xie, et al.. (2017). Research progress on DNA methylation in hepatocellular carcinoma. Translational Cancer Research. 6(5). 981–998.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026